CAMP4 THERAPEUTICS CORPORATION
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | -274.5% | – | – | |
| – | +1.2% | +0.2% | -2.8% | -1.4% | +0.0% | +0.7% | +2.1% | -3.3% | -10.6% | +39.8% | -1.0% | – | |
| – | -11.9% | +34.6% | -8.2% | +102.5% | -49.9% | +8.0% | +16.4% | -1.8% | +17.0% | +27.9% | +31.2% | – | |
| – | -104.5% | – | – | – | +235.4% | -584.5% | – | -186.2% | – | -105.2% | – | – | |
| – | +17.4% | -93.8% | +986.7% | -100.0% | – | +6.1% | -100.0% | – | – | – | – | – | |
| – | +17.4% | -93.8% | +986.7% | +9.2% | +47.8% | +6.1% | +0.0% | – | – | – | – | – | |
| – | – | – | – | – | +6.7% | -62.5% | +19.4% | -67.4% | +28.6% | -100.0% | – | – | |
| – | -69.0% | +220.6% | +302.0% | -52.5% | – | -100.2% | – | +65,711.1% | -39.7% | -99.8% | -93.0% | – | |
| – | – | – | – | – | – | -123.9% | – | – | -3.7% | -131.3% | – | – | |
| – | – | – | – | – | – | – | – | – | – | -274.5% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.